Deal value increased by 19.2 per cent in Jan 2024, compared to Jan 2023: GlobalData
VC investments increased by 11.2 per cent in Jan 2024, compared to Jan 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Zydus gets tentative USFDA approval for Dexamethasone Tablets USP, 1 mg
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye…
Biocon Biologics Partners with Sandoz Australia for Trastuzumab and Bevacizumab
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
Algorithmic Biologics secures Pre-Series A funding
Proceeds of the fundraise will be used to support the product pipeline, building the sales organisation and furthering their…
Zydus gets USFDA nod for Dexamethasone Tablets USP, 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg and…
Dexamethasone is used to treat a number of different conditions, such as inflammation (swelling), severe allergies, adrenal…
Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData
The acquisition of Catalent by Novo Holdings expects to see three new manufacturing sites added to Novo Nordisk’s arsenal, to…
DHL Express India and Aragen LifeSciences sign GoGreen Plus partnership to reduce carbon emission
GoGreen Plus uses sustainable aviation fuel (SAF) to enable customers to reduce Scope 3 emissions
RxP expands life sciences real estate portfolio in Mumbai with $150+mn investment
RxP announces its expansion in Mumbai with the Navi Mumbai Research (NMR) District as part of its continued regional expansion…
US FDA gives record number of review designations to CRISPR drugs in 2023: GlobalData
Casgevy is the first CRISPR-based drug to receive marketing authorisation globally
SGD Pharma introduces new range of Type I tubular vials
It features Corning’s Velocity Vial coating technology
Merck seeks to develop novel T-cell engager therapies with TriTAC platform: GlobalData
The deal includes the novel HPN-217 and HPN-328 compounds, which are currently undergoing Phase II clinical trials for various…
Phase 3 trial data confirm efficacy and safety profile of R21/Matrix-M malaria vaccine in African…
Investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78 per…
Lupin gets US FDA nod for Dronedarone Tablets, USP
They are indicated to reduce the risk of hospitalisation for atrial fibrillation (AF) in patients in sinus rhythm with a history…
Drug price controls and emphasis on preventive care top solutions to address healthcare inflation:…
Inflation in healthcare refers to the persistent increase in the cost of medical goods and services over time. This phenomenon is…
Glenmark partners with Pfizer to launch Abrocitinib in India
When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively
AstraZeneca and Sanofi Beyfortus to dominate RSV market in China: GlobalData
In 2017, Sanofi entered into a collaboration agreement with MedImmune (AstraZeneca) to jointly develop and commercialise Beyfortus
Jubilant Pharma to sell its 25.8 per cent stake in Sofie Biosciences for $139.43 mn
Of this, $113.63 million is expected to be received upon completion of the merger while receipt of balance sum of $25.8 million is…
Glenmark and Ichnos launch Ichnos Glenmark Innovation to accelerate new drug discovery in cancer…
The newly formed IGI features a pipeline of three innovative oncology molecules targeting multiple myeloma, acute myeloid leukemia…
Zydus launches Rexigo, oral once-a-day pill to treat advanced prostate cancer
Relugolix is reportedly the only oral option of ADT drugs known as gonadotropin releasing hormone (GnRH) analogues
Orchid Pharma gets EMA approval for Exblifep
Exblifep has received EMA's recommendation for marketing authorization for use in treatment of complicated urinary tract…